Daniel E. Geffken
CIK 1314756 · Interim CFO · last filed 2024-05-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.5K
Companies
7
Total Filings
14
Lifetime Open-Market Net
$51.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CALC | Interim CFO | — | $0.72 | — | $0 | 2 | 2024-05-20 |
| CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Chief Financial Officer | 10,002 | $0.05 | $501 | $0 | 1 | 2024-02-16 |
| PMN | Chief Financial Officer | — | $14.52 | — | $0 | 1 | 2023-10-30 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) Delisted | Director | 2 | $0.01 | $0 | $15.0K | 6 | 2023-08-29 |
| ELOX | INTERIM CFO | 114 | $12.81 | $1.5K | $36.0K | 2 | 2021-12-01 |
| CERO THERAPEUTICS HOLDINGS, INC. (PBAXU) Delisted | Chief Financial Officer | — | $10.37 | — | $0 | 1 | 2021-10-12 |
| LWACU | Chief Financial Officer | — | $10.32 | — | $0 | 1 | 2021-01-14 |
Recent Filings · Page 2 of 2
14 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-05 | WINDTREE THERAPEUTICS INC /DE/ (WINT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-14 | LWACU | Other (J) | — | $0 | EDGAR |
| 2020-05-27 | WINDTREE THERAPEUTICS INC /DE/ (WINT) Delisted | Buy (P) | +2,069 | $15.0K | EDGAR |
| 2019-04-26 | WINDTREE THERAPEUTICS INC /DE/ (WINT) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–14 of 14
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.